India, April 9 -- The longevity and bio-hacking sector of medicine is known to be highly experimental, with a lot being pushed by fitness and health influencers that still requires significant testing.

One of the compounds that is now getting its time in the spotlight is rapamycin, which, according to Dr Vassily Eliopoulos, a longevity expert trained at Cornell University and co-founder and chief medical officer of Longevity Health, is the most controversial drug in this market at present.

Taking to Instagram on April 9, Dr Vass explained what the drug is, and how far it is along in the testing process, and the likely effects of administering it in humans.

The drug rapamycin has been approved by the FDA since the 1990s, shared Dr Vass....